Biotech Acquisition Co - Ordinary Shares - Class A

NASDAQ:BIOT   11:09:50 AM EDT
9.85
+0.04 (+0.41%)
Debt Financing / Related, Name Changes, Mergers / Acquisitions

Biotech Acquisition Company And Blade Therapeutics To Combine

Published: 11/08/2021 13:28 GMT
Biotech Acquisition Co - Ordinary Shares - Class A (BIOT) - Biotech Acquisition Company and Blade Therapeutics Announce Definitive Merger Agreement.
Biotech Acquisition Co - Combined Company Expected to Have Post-transaction Enterprise Value of Approximately $352.8 Million.
Biotech Acquisition Co - Deal Expected to Provide Pro Forma Cash Balance of About $254.3 Million to Combined Company.
Biotech Acquisition Co - Deal Includes About $24.3 Million Pipe Financing Anchored by Leading Institutional Investors.
Biotech Acquisition Co - Combined Company Will Be Renamed Blade Biotherapeutics Inc, and is Expected to Be Listed on Nasdaq Under Symbol "bbtx".